Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
719 Phase 1 study of the porcupine (PORCN) inhibitor RXC004 in combination with the PD-1 inhibitor nivolumab in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.